The direct effect of fibroblast growth factor 23 on vascular smooth muscle cell phenotype and function

By sjmartinez • February 15, 2023

Vergara N, de Mier MVP, Rodelo-Haad C, Revilla-González G, Membrives C, Díaz-Tocados JM, Martínez-Moreno JM, Torralbo AI, Herencia C, Rodríguez-Ortiz ME, López-Baltanás R, Richards WG, Felsenfeld A, Almadén Y, Martin-Malo A, Ureña J, Santamaría R, Soriano S, Rodríguez M, Muñoz-Castañeda JR. The direct effect of fibroblast growth factor 23 on vascular smooth muscle cell phenotype and function. Nephrol Dial Transplant. 2023 Feb 13;38(2):322-343. doi: 10.1093/ndt/gfac220. PMID: 35867864; PMCID: PMC9923714.

Tags: arterial stiffness, Chronic kidney disease, FGF23, microRNA, Nephrology, Publications, vascular smooth muscle cells

Intravitreal vascular endothelial growth factor inhibitor systemic and renal toxicity registry

Nguyen MD, Fekrat R, Gee C, Demirci AN, Kharabaf S, Le D, Tadros M, Nguyen VQ, Patel S, Truong T, Ahdoot R, Kurtz IB, Kerr[...]

Management recommendations for kidney transplantation in patients with plasma cell dyscrasia

Murakami N, Blosser CD, Webber AB, Gupta G, Singh N, Boppana S, Master S, Parasuraman R, Campagnaro EL, Java A, Sprangers B, Bhasin-Chhabra B, Lum[...]

Experiences and perspectives of patients and their caregivers on gastrointestinal symptoms in peritoneal dialysis: Workshop report

Hayat A, Johnson DW, Manera K, Viecelli AK, Wilkie M, Shen J, Wang AY, Htay H, Jaure A, Cho Y, Walker R. Experiences and perspectives[...]